In the case of this ID glitch, there was no way to return to any aspect of the intake, nor was there any prompt regarding the missing images
Note that this trial used semaglutide at 1.0 mg - the glycemic-management dose - rather than the 2.4 mg dose used for weight management (Wegovy)
What the Evidence Shows and What It Does Not The study found an association, not proof of direct drug causation
Compared with the general population, the relative risk (RR) of developing HF in people with T2DM is twofold higher for men and fivefold higher for women [25]
The constellation of risk factor improvements provides reasonable expectation of cardiovascular benefit that formal trials may confirm
28 The stability of the human DBD is relatively poor, and it can dissolve at temperatures slightly above body temperature, which affects the stability of the full-length p53 protein